Introduction {#sec1_1}
============

Pigmented epithelioid melanocytoma (PEM), also known as an animal-type melanoma, is a distinctive group of melanocytic tumors with a more favorable prognosis than conventional melanoma \[[@B1], [@B2], [@B3]\]. The typical PEM contains an aggregation of histiocytes in the center of the tumor, which is useful for the differential diagnosis against nodular melanomas or cellular blue nevus \[[@B3], [@B4], [@B5], [@B6]\]. As we previously reported, these aggregated histiocytes contain M2-like macrophages \[[@B7]\], which could be either positive or negative prognostic factors for skin cancers when stimulated by different cancer stromas \[[@B8]\]. Therefore, in this report, we further investigate the subpopulation of tumor-associated macrophages (TAMs) in PEM.

Case Report {#sec1_2}
===========

A 60-year-old Japanese man visited our outpatient clinic with a 20-year history of a black nodule on the nose, which was histologically suspected to be a nodular melanoma. On his initial visit, physical examination revealed a blue-black, dome-shaped nodule, 10 mm in size, on the nose (Fig. [1a](#F1){ref-type="fig"}). A biopsy specimen from the nodule revealed the proliferation of epithelioid, pleomorphic, atypical cells with heavy pigmentation in the dermis and aggregation of histiocytes (Fig. [1b](#F1){ref-type="fig"}). Immunohistochemical staining revealed that these atypical cells were positive for HMB45 and Melan A. From the above findings, our diagnosis was PEM (animal types of melanoma) on the nose. We excised the tumor with a 5-mm margin.

The biological behaviors of PEM were reported to have a favorable prognosis compared to conventional nodular melanoma \[[@B1], [@B3]\], but little is known about the immunological microenvironment of PEM. Therefore, we employed immunohistochemical staining for CD163, CD205, CD206, and PD-L1, focusing on the profiles of tumor-infiltrating histiocytes, which are pathologically different from those of conventional nodular melanoma. The histiocytic area was composed of both CD163+ CD206+ M2-polarized macrophages (Fig. [2a](#F2){ref-type="fig"}) and CD205+ dendritic cells (Fig. [2b](#F2){ref-type="fig"}). In addition, most of these histiocytes highly expressed PD-L1 (Fig. [2c](#F2){ref-type="fig"}).

Discussion {#sec1_3}
==========

PEM is a distinctive group of melanocytic tumors, which only rarely metastasize to regional lymph nodes compared to nodular melanoma \[[@B1], [@B3]\]. Since TAMs extend to the premetastatic lymph nodes in several cancers \[[@B9], [@B10]\], we hypothesized that the lower rate of lymph node metastasis in PEM might be correlated with the phenotypes of TAMs.

TAMs comprise an immunosuppressive microenvironment together with other suppressor cells, such as regulatory T cells, in the tumor-bearing host \[[@B11]\]. As Perry et al. \[[@B12]\] reported, reprogramming TAMs into inflammatory phenotypes by targeting CD40 and CD115 suppresses melanoma growth in vivo, suggesting that the phenotypes of TAMs could determine the progression of melanoma. Notably, PEM also possesses various TAMs, including CD163+ M2 macrophages \[[@B7]\], suggesting the importance of investigating the subtypes of TAMs. Since investigating the phenotypes of TAMs in skin tumors is important to estimate their biological behaviors \[[@B8], [@B13]\], in this report, we further determined the subpopulation of TAMs in PEM.

In our present case, the histiocytic area was mainly composed of CD163+CD206+ M2-polarized macrophages and CD205+ dendritic cells, both of which could express PD-L1 by the stimulation of cancer stromal factors to induce an immunosuppressive microenvironment at the tumor sites \[[@B11], [@B14]\]. Notably, since the expression of PD-L1 on TAMs was associated with high levels of CD4+ and CD8+ tumor-infiltrating lymphocytes \[[@B15]\], the PD-L1-expressing TAMs and dendritic cells might suggest favorable prognostic factors in patients with PEM. Since we present only a single case, further cases are needed to gain additional insight into the pathomechanisms of PEM.
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![**a** A blue-black, dome-shaped nodule, 10 mm in size, on the nose. **b**, **c** A proliferation of epithelioid, pleomorphic, atypical cells with heavy pigmentation in the dermis and aggregation of histiocytes. Original magnification: ×50 (**a**), ×400 (**c**).](cro-0011-0378-g01){#F1}

![Paraffin-embedded samples were deparaffinized and stained with anti-CD163 Abs (**a**), anti-CD205 Abs (**b**), anti-CD206 Abs (**c**), and anti-PD-L1 Abs (**d**). The sections were developed with liquid permanent red. Original magnification: ×200.](cro-0011-0378-g02){#F2}
